ARCHIVES

Clinical Oncology Study Section In Draft; ET2 May Be Eliminated, NIH Official Says

This article is from The Cancer Letter archive.

Vol. 24 No. 06 | February 13, 1998

Download PDF Visit The Full Archive

Related Articles

Perjeta, Herceptin & Docetaxel Combination Extended Survival in HER2-Positive Disease

December 28, 2012

Stronger Measures Needed To Reduce U.S. Smoking, IOM Says.

June 1, 2007

Hatch Committee Clears Bill Blocking OMB Micromanagement

August 15, 1986

In Brief: Public Favors stronger Laws Restricting Teen Smoking; Anderson Expands Pediatric Studies

April 26, 1991

DeVita On Problems Of Drug Response: There May be Tw Populations Of Cells; Molecular Medicine will Change Treatment

December 13, 1991

NCI Objects To Fisher As Scientific Director Of NSABP, Threatens To Cut Off Funding

May 6, 1994